Adam Waickman

Assistant Professor

SUNY Upstate Medical University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adam Waickman is an Assistant Professor at SUNY Upstate Medical University in the United States. His research focuses on immunological responses to viral infections, particularly dengue virus and HIV-1. Recent publications include studies on MAIT cell responses, monocyte gene expression profiles, and the development of monoclonal antibodies for dengue treatment. He is actively engaged in advancing our understanding of immune responses to various infectious challenges.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Johan K. Sandberg

Professor

Karolinska Institutet

SWEDEN

View details

Michael McCracken

Interim Chief of Medical Countermeasures Department

Walter Reed Army Institute of Research

UNITED STATES

View details

Carmen Molina‐París

UNITED KINGDOM

View details

Stephen Thomas

Professor of Medicine

SUNY Upstate Medical University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adam Waickman

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

The MAIT cell response to controlled oral enterotoxigenic E. coli challenge

Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts

Conventional and antibody-enhanced DENV infection of human macrophages induces differential immunotranscriptomic profiles

Development and optimization of an mRNA-vectored single-chain IgA1 isotype monoclonal antibody with potential to treat or prevent dengue virus infection

Low-dose dengue virus 3 human challenge model: a phase 1 open-label study

Dengue Virus Structural Proteins Are Expressed on the Surface of DENV-Infected Cells and Are a Target for Antibody-Dependent Cellular Phagocytosis

DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection

Biologics for dengue prevention: up-to-date

Simultaneous analysis of antigen-specific B and T cells after SARS-CoV-2 infection and vaccination

Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors

Evolution of inflammation and immunity in a dengue virus 1 human infection model

Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections

Analysis of cell-associated DENV RNA by oligo(dT) primed 5’ capture scRNAseq

The Cytokine Receptor IL-7Rα Impairs IL-2 Receptor Signaling and Constrains the In Vitro Differentiation of Foxp3<sup>+</sup> Treg Cells

Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection

Collaborators (4)

Johan K. Sandberg

Michael McCracken

Carmen Molina‐París

Stephen Thomas

Make your next move.